Comparative drug tests make pharma see red. But market pressure to prove a drug's real-world value is likely to force even the most stubborn firm into the ring. Why be bull-headed? Adaptive trials can cut cost, time, and risk in half.
Clinical trials exist in a very competitive environment, where multiple trials are vying for a limited pool of potential participants. It has become necessary for trial directors to view recruitment as a marketing effort.